Indegene Ltd Board Meeting on Oct 29 to Approve Unaudited Results

Indegene Ltd has announced that its Board of Directors will convene on October 29, 2026. The primary agenda for this meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The meeting will also address the allotment of shares under the RSU Scheme 2020 and ESOP Scheme 2020. Concurrently, the trading window for the company's securities will remain closed from October 1, 2026, until 48 hours after the declaration of these financial results.